Search Tag: Edwards Lifesciences

ICU Management

FDA Clearance For Edwards’ Advanced Noninvasive Monitoring System

2014 05 Jul

ClearSight system enables clinicians to reduce risk of post-surgical complications Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, has announced it has received U.S. Food and Drug Administration (FDA) clearance for the ClearSight system.  The ClearSight system is a noninvasive... Read more

ICU Management

ISICEM 2014: Raising Standards of Care in Glucose Management

2014 18 Mar

Edwards Lunch Symposium Thursday, March 20 12.30–13.30 Arc Room (level 3) Improving glycemic control with continuous glucose monitoring Chair : A. Rhodes (London, England) Association between glucose levels and patient outcomes –analysis of a large patient dataset A.Rhodes (London, England) Continuous glucosemonitoring in ICU... Read more

Cardiology Management

Edwards' Transcatheter Valve Patent Infringement Confirmed

2014 22 Jan

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, announced that a federal jury found Edwards' United States Cribier transcatheter heart valve patent valid, and that Medtronic CoreValve LLC willfully infringes it.  Edwards will move to enforce this verdict and intends to seek a permanent... Read more

Cardiology Management

US Trial of Edwards’ Sapien3 Valve to Begin

2014 15 Jan

Enrollment Completed in Trial of High-Risk Patients Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, announced that it received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate a single-arm, non-randomised clinical trial of... Read more